Combinations of ssri and estrogenic agents
CA 2414938 A1 · Owner: Wyeth · Inventors: Jenkins, Simon Nicholas
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention comprises methods of treating depression anxiety, generalized anxiety disorder (GAD) hot flush, post partum depression, premenstrual syndrome obesity, obsessive compulsive disorder post-traumatic stress disorder, social phobia disruptive behavior disorders, impulse control disorders borderline personality disorder, chronic fatigue disorder premature ejaculation, pain, attention deficit disorders with and without hyperactivity, Gilles de la Tourette syndrome bulimia nervosa, or Shy Drager Syndrome comprising administration of a selective serotonin reuptake inhibitor and compound of the formula (I) or (II): wherein Z is a moiety selected from the group of: wherein: R¿1? is …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 29, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 29, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 29, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.